HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$5.73
Day range
$5.26 - $5.80
Year range
$3.50 - $10.24
Market cap
185.24M USD
Avg Volume
65.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 8.26M | 44.40% |
Operating expense | 14.62M | -37.99% |
Net income | -10.11M | 71.53% |
Net profit margin | -122.36 | 80.29% |
Earnings per share | -0.40 | 74.36% |
EBITDA | -7.41M | 59.38% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.52M | -27.61% |
Total assets | 23.97M | -6.82% |
Total liabilities | 49.86M | -3.48% |
Total equity | -25.89M | — |
Shares outstanding | 31.28M | — |
Price to book | -6.90 | — |
Return on assets | -73.67% | — |
Return on capital | -5,046.60% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.11M | 71.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2009
Headquarters
Website
Employees
116
